Page last updated: 2024-10-31

nocodazole and Carcinoma, Ovarian Epithelial

nocodazole has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

Carcinoma, Ovarian Epithelial: A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santibáñez, M1
Gallardo, D1
Morales, F1
López, A1
Prada, D1
Mendoza, J1
Castro, C1
de León, DC1
Oñate, LF1
Perez, D1
Mohar, A1
Herrera, LA1

Other Studies

1 other study available for nocodazole and Carcinoma, Ovarian Epithelial

ArticleYear
The MAD1 1673 G → A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer.
    Pharmacogenetics and genomics, 2013, Volume: 23, Issue:4

    Topics: Biomarkers, Pharmacological; Calcium-Binding Proteins; Carcinoma, Ovarian Epithelial; Cell Cycle Pro

2013